» Articles » PMID: 17304217

Extracellular Heat Shock Protein-90alpha: Linking Hypoxia to Skin Cell Motility and Wound Healing

Overview
Journal EMBO J
Date 2007 Feb 17
PMID 17304217
Citations 150
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia is a microenvironmental stress in wounded skin, where it supports wound healing by promoting cell motility. The mechanism of the hypoxia action remained speculative. Here, we provide evidence that hypoxia promotes human dermal fibroblast (HDF) migration by inducing secretion of heat shock protein-90alpha (hsp90alpha) into the extracellular environment through hypoxia-inducible factor-1alpha (HIF-1alpha). The secreted hsp90alpha in turn executes hypoxia's pro-motility effect. Expression of an activated HIF-1alpha mimicked, whereas expression of an inactive HIF-1alpha or suppression of endogenous HIF-1alpha blocked, hypoxia-induced hsp90alpha secretion and HDF migration. Interestingly, the hypoxia-HIF-1 pathway-induced hsp90alpha secretion required neither changes in the steady-state mRNA level nor in the promoter activity of hsp90alpha. Recombinant hsp90alpha fully duplicated the hypoxia effect on HDFs. Inhibition of extracellular hsp90alpha function completely blocked the hypoxia-HIF-1 pathway-stimulated HDF migration. More intriguingly, topical application of hsp90alpha accelerated wound healing in mice. This study has demonstrated a novel mechanism of hypoxia>HIF-1>hsp90alpha secretion>skin cell migration>wound healing, and identified extracellular hsp90alpha as a potential therapeutic agent for skin wounds.

Citing Articles

Upregulation of HSP90α in the lungs and circulation in sarcoidosis.

Isshiki T, Sunakawa M, Vierhout M, Ayoub A, Ali P, Naiel S Front Med (Lausanne). 2025; 12:1532437.

PMID: 39881845 PMC: 11774731. DOI: 10.3389/fmed.2025.1532437.


An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.

Alqabandi J, David R, Abdel-Motal U, ElAbd R, Youcef-Toumi K Sci Rep. 2024; 14(1):30107.

PMID: 39627312 PMC: 11615046. DOI: 10.1038/s41598-024-79154-z.


Discovery of Cell Number-Interstitial Fluid Volume (CIF) Ratio Reveals Secretory Autophagy Pathway to Supply eHsp90α for Wound Healing.

Chang C, Tang X, Schonthal A, Chen M, Woodley D, Wang Y Cells. 2024; 13(15.

PMID: 39120311 PMC: 11312289. DOI: 10.3390/cells13151280.


The therapeutic efficacy of different configuration nano-polydopamine drug carrier systems with photothermal synergy against head and neck squamous cell carcinoma.

Guo Y, Li B, Xie H, Wu C, Wang G, Yao K Regen Biomater. 2024; 11:rbae073.

PMID: 39027362 PMC: 11256922. DOI: 10.1093/rb/rbae073.


Translational Challenges in Drug Therapy and Delivery Systems for Treating Chronic Lower Extremity Wounds.

Aljamal D, Iyengar P, Nguyen T Pharmaceutics. 2024; 16(6).

PMID: 38931872 PMC: 11207742. DOI: 10.3390/pharmaceutics16060750.


References
1.
Young J, Moarefi I, Hartl F . Hsp90: a specialized but essential protein-folding tool. J Cell Biol. 2001; 154(2):267-73. PMC: 2150759. DOI: 10.1083/jcb.200104079. View

2.
Denzer K, Kleijmeer M, Heijnen H, Stoorvogel W, Geuze H . Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci. 2000; 113 Pt 19:3365-74. DOI: 10.1242/jcs.113.19.3365. View

3.
Richter K, Buchner J . Hsp90: chaperoning signal transduction. J Cell Physiol. 2001; 188(3):281-90. DOI: 10.1002/jcp.1131. View

4.
. The phagokinetic tracks of 3T3 cells. Cell. 1977; 11(2):395-404. DOI: 10.1016/0092-8674(77)90057-5. View

5.
Workman P . The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones. Cancer Chemother Pharmacol. 2003; 52 Suppl 1:S45-56. DOI: 10.1007/s00280-003-0593-0. View